All lobbying filings

SOLUGEN INC

SOLUGEN INC filed a Q4 report for SOLUGEN INC on January 16, 2026.

Lobbying for SOLUGEN INC · Industrial Biomanufacturing

All filings by SOLUGEN INC · Everything SOLUGEN INC has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Expenses

$160,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Defense

Support the use of bio-based chemicals in the Department of Defense, generally. Department of Defense Appropriations Act, 2026 (H.R.4016/ S.2572 - 119th Congress). National Defense Authorization Act for Fiscal Year 2026 (S.2296 - 119th Congress).

Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally.

Bills named in this filing 3

H.R. 4016
Department of Defense Appropriations Act, 2026
S. 2572
Department of Defense Appropriations Act, 2026
S. 2296
National Defense Authorization Act for Fiscal Year 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.